BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25215298)

  • 1. Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.
    Shen Y; Zhang S; Huang X; Chen K; Shen J; Wang Z
    Biomed Res Int; 2014; 2014():920275. PubMed ID: 25215298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
    Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
    Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.
    Zhou J; Xiong R; Zhou J; Guan X; Jiang G; Chen Y; Yang Q
    Toxicol Appl Pharmacol; 2022 Feb; 436():115849. PubMed ID: 34974052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
    Balogh GA; Russo IH; Russo J
    Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.
    Shinsato Y; Furukawa T; Yunoue S; Yonezawa H; Minami K; Nishizawa Y; Ikeda R; Kawahara K; Yamamoto M; Hirano H; Tokimura H; Arita K
    Oncotarget; 2013 Dec; 4(12):2261-70. PubMed ID: 24259277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!
    Fadhil W; Field J; Cross G; Kaye P; Ilyas M
    Histopathology; 2012 Sep; 61(3):522-5. PubMed ID: 22642480
    [No Abstract]   [Full Text] [Related]  

  • 8. Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases.
    Pai RK; Plesec TP; Abdul-Karim FW; Yang B; Marquard J; Shadrach B; Roma AR
    Am J Surg Pathol; 2015 Jul; 39(7):993-9. PubMed ID: 25786082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
    Backes FJ; Leon ME; Ivanov I; Suarez A; Frankel WL; Hampel H; Fowler JM; Copeland LJ; O'Malley DM; Cohn DE
    Gynecol Oncol; 2009 Sep; 114(3):486-90. PubMed ID: 19515405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?
    Shia J; Stadler Z; Weiser MR; Rentz M; Gonen M; Tang LH; Vakiani E; Katabi N; Xiong X; Markowitz AJ; Shike M; Guillem J; Klimstra DS
    Am J Surg Pathol; 2011 Mar; 35(3):447-54. PubMed ID: 21297438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells.
    Doukas SG; Vageli DP; Lazopoulos G; Spandidos DA; Sasaki CT; Tsatsakis A
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
    Case AS; Zighelboim I; Mutch DG; Babb SA; Schmidt AP; Whelan AJ; Thibodeau SN; Goodfellow PJ
    Gynecol Oncol; 2008 Feb; 108(2):438-44. PubMed ID: 18022218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
    Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
    Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
    Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.
    Collins SL; Hervé R; Keevil CW; Blaydes JP; Webb JS
    PLoS One; 2011; 6(12):e28123. PubMed ID: 22145025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
    Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
    Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
    Edwards RA; Witherspoon M; Wang K; Afrasiabi K; Pham T; Birnbaumer L; Lipkin SM
    Cancer Res; 2009 Aug; 69(16):6423-9. PubMed ID: 19638594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.